Skip to main content
logo
Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
4.000
+0.150 (3.90%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Nasus Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
4783---
Market Cap Growth
-37.70%----
Enterprise Value
3585---
Last Close Price
4.009.15---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
4.2629.95---
P/TBV Ratio
4.2629.95---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.04-0.56-0.65-0.56
Net Debt / Equity Ratio
-1.06-1.51-0.47-0.60-0.51
Net Debt / FCF Ratio
1.110.85-2.28-2.20-1.17
Quick Ratio
8.421.980.070.050.05
Current Ratio
8.772.250.120.110.13
Return on Assets (ROA)
-96.73%-107.15%-116.06%-166.52%-
Return on Capital Employed (ROCE)
-91.70%-172.60%33.60%30.20%73.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-22.51%-7.06%---
FCF Yield
-22.50%-5.95%---
Buyback Yield / Dilution
-38.03%-13.98%0.43%-2.44%-
SEC Filings: 10-K · 10-Q